echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > A new study reveals why HIV persists in human tissues even after antiretroviral therapy

    A new study reveals why HIV persists in human tissues even after antiretroviral therapy

    • Last Update: 2022-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Now, a new study by University of Alberta immunologist Shokrollah Elahi sheds light on why infected people are not completely free from HIV


    Elahi and his team found that in AIDS patients, killer T cells -- a type of white blood cell responsible for recognizing and destroying virus-infected cells -- were almost devoid of a protein called CD73


    Because CD73 is responsible for cell migration and movement into tissues, lack of this protein impairs the ability of T-killer cells to find and destroy HIV-infected cells, Elahi explained


    "This mechanism explains one potential reason why HIV remains permanently in human tissues,


    "This gives us an opportunity to come up with potential new treatments that help killer T cells migrate better to access infected cells in different tissues


    After identifying the role of CD73 (a three-year project), Elahi turned his focus to understanding the underlying reasons for the dramatic decrease


    He explained: "After extensive research, we found that chronic inflammation leads to increased levels of a type of RNA found in cells and blood called microRNAs


    The team's findings also help explain why people with HIV have a lower risk of developing multiple sclerosis, Irahi noted


    "Our findings suggest that reducing or eliminating CD73 could be beneficial in HIV-infected individuals to protect them from MS


    Elahi said the next steps in his research include determining how to manipulate the CD73 gene to turn it on in people with AIDS and turn it off in people with multiple sclerosis



    Shima Shahbaz, Isobel Okoye, Gregg Blevins, Shokrollah Elahi.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.